It’s a start, but why is it left to a company to absorb and submit the tax. It shouldn’t be limited to just one company. Congratulations to canopy growth for seeing the benefit of why tax should not be applied to a product that is used for medicinal reasons. It’s one small step but a larger message needs to be shared in regards to telling our government that we need access, and no tax applicable to our medicine CLICK THE LINK to download the full Media release CFAMM-June-13-2018-Canopy-press-release
